MSB 0.36% $1.39 mesoblast limited

Ann: Mesoblast Update on Chronic Low Back Pain Program, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 265 Posts.
    lightbulb Created with Sketch. 163
    "Mesoblast plans to leverage the results from a planned US trial to support potential product approvals
    in both US and EU".

    Educate me please. If they've had a successful Phase 3 trial, why do they need another trial?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.